| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +123.0% |
| Cost of Revenue | $62K | +682.1% |
| Gross Profit | $142K | +166.7% |
| R&D Expense | $1.8M | +31.3% |
| SG&A Expense | $7.9M | -20.0% |
| Operating Income | -$9.6M | +16.5% |
| Pre-tax Income | -$11.1M | +17.7% |
| Net Income | -$11.1M | +17.7% |
| EPS (Basic) | -$0.96 | +32.9% |
| EPS (Diluted) | -$0.96 | +32.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $792K | -76.6% |
| Accounts Receivable | $2.0M | -36.2% |
| Current Assets | $2.9M | -56.0% |
| Total Assets | $4.6M | -43.4% |
| Current Liabilities | $7.4M | -32.8% |
| Long-term Debt | $268K | -37.7% |
| Total Liabilities | $7.8M | -35.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +18.5% |
| Investing Cash Flow | -$2K | — |
| Financing Cash Flow | $2.7M | -69.0% |
| Stockholders' Equity |
| -$3.2M |
| +19.7% |